A Closer Look at 28 Analyst Recommendations For Sarepta Therapeutics
A Closer Look at 28 Analyst Recommendations For Sarepta Therapeutics
對Sarepta Therapeutics的28個分析師建議進行更詳細的分析
A comprehensive examination of how...Sarepta Therapeutics (NASDAQ:SRPT) has been analyzed by 28 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Sarepta Therapeutics（納斯達克:SRPT）在過去三個月內已經受到28位分析師的分析，揭示了從看好到看淡的各種不同觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $185.0, a high estimate of $235.00, and a low estimate of $128.00. This current average has increased by 6.54% from the previous average price target of $173.65.
分析師分析了12個月的價格目標，提供了平均目標185.0美元，最高估價235.00美元和最低估價128.00美元的見解。該當前平均值比之前的平均目標價173.65美元增加了6.54%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
A comprehensive examination of how...
對Sare...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間